BridgeMD
Tests treatment safety and results for Schizophrenia
Official title A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
ClinicalTrials.gov ID: NCT07424404
What this study is testing
What is KarXT?
KarXT is an investigational medicine, being studied as a potential treatment for schizophrenia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to evaluate the long-term safety and tolerability of KarXT and KarX-EC for the treatment of Schizophrenia and autism-related irritability in adolescents, respectively
- Phase 3: a large, late-stage study
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 17
You may be able to join if
- \- Participants must have completed the blinded treatment period (ie, Visit 8) of Study CN0120020 or the blinded treatment period (ie, Week 8) of...
You likely can't join if
- Participants must not have a significant risk of committing violent acts, serious self-harm, or attempting suicide based on history or routine...
- Participants must not have any clinically significant abnormality including any finding(s) from the physical examination, vital signs, ECG at the end...
- Participants must not have either a systolic blood pressure (sBP) or diastolic blood pressure (dBP) meeting criteria for stage 2 hypertension (HTN)...
- Other protocol-defined Inclusion/Exclusion criteria apply.
The study team makes the final eligibility decision.
Where it's taking place
- Dothan, Alabama, United States
- Phoenix, Arizona, United States
- Anaheim, California, United States
- Chino, California, United States
- Culver City, California, United States
- Glendale, California, United States
- Los Angeles, California, United States
- Orange, California, United States
- Redlands, California, United States
- San Francisco, California, United States
- San Rafael, California, United States
- Colorado Springs, Colorado, United States
- New Haven, Connecticut, United States
- Boca Raton, Florida, United States
- Gainesville, Florida, United States
- Hollywood, Florida, United States
- Orange City, Florida, United States
- Orlando, Florida, United States
- Atlanta, Georgia, United States
- Lawrenceville, Georgia, United States
+ 68 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dothan, Alabama, United States; Phoenix, Arizona, United States; Anaheim, California, United States; Chino, California, United States; Culver City, California, United States; Glendale, California, United States and 82 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.